Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study
- PMID: 18519904
- PMCID: PMC2396352
- DOI: 10.1503/cmaj.071594
Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study
Abstract
Background: Medication-related visits to the emergency department are an important but poorly understood phenomenon. We sought to evaluate the frequency, severity and preventability of drug-related visits to the emergency department.
Methods: We performed a prospective observational study of randomly selected adults presenting to the emergency department over a 12-week period. Emergency department visits were identified as drug-related on the basis of assessment by a pharmacist research assistant and an emergency physician; discrepancies were adjudicated by 2 independent reviewers.
Results: Among the 1017 patients included in the study, the emergency department visit was identified as drug-related for 122 patients (12.0%, 95% confidence interval [CI] 10.1%-14.2%); of these, 83 visits (68.0%, 95% CI 59.0%-76.2%) were deemed preventable. Severity was classified as mild in 15.6% of the 122 cases, moderate in 74.6% and severe in 9.8%. The most common reasons for drug-related visits were adverse drug reactions (39.3%), nonadherence (27.9%) and use of the wrong or suboptimal drug (11.5%). The probability of admission was significantly higher among patients who had a drug-related visit than among those whose visit was not drug-related (OR 2.18, 95% CI 1.46-3.27, p < 0.001), and among those admitted, the median length of stay was longer (8.0 [interquartile range 23.5] v. 5.5 [interquartile range 10.0] days, p = 0.06).
Interpretation: More than 1 in 9 emergency department visits are due to drug-related adverse events, a potentially preventable problem in our health care system.
Figures

Similar articles
-
Medication-related emergency department visits in pediatrics: a prospective observational study.Pediatrics. 2015 Mar;135(3):435-43. doi: 10.1542/peds.2014-1827. Epub 2015 Feb 2. Pediatrics. 2015. PMID: 25647671
-
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.BMC Pharmacol Toxicol. 2019 Apr 27;20(1):21. doi: 10.1186/s40360-019-0297-7. BMC Pharmacol Toxicol. 2019. PMID: 31029178 Free PMC article.
-
Do emergency physicians attribute drug-related emergency department visits to medication-related problems?Ann Emerg Med. 2010 Jun;55(6):493-502.e4. doi: 10.1016/j.annemergmed.2009.10.008. Epub 2009 Dec 11. Ann Emerg Med. 2010. PMID: 20005010
-
Drug-related visits to the emergency department: how big is the problem?Pharmacotherapy. 2002 Jul;22(7):915-23. doi: 10.1592/phco.22.11.915.33630. Pharmacotherapy. 2002. PMID: 12126224 Review.
-
Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review.J Am Geriatr Soc. 2018 Mar;66(3):602-608. doi: 10.1111/jgs.15244. Epub 2018 Feb 22. J Am Geriatr Soc. 2018. PMID: 29468640
Cited by
-
Impact of systematic medication review in emergency department on patients' post-discharge outcomes-A randomized controlled clinical trial.PLoS One. 2022 Sep 19;17(9):e0274907. doi: 10.1371/journal.pone.0274907. eCollection 2022. PLoS One. 2022. PMID: 36121830 Free PMC article. Clinical Trial.
-
Detection of adverse drug events in e-prescribing and administrative health data: a validation study.BMC Health Serv Res. 2021 Apr 23;21(1):376. doi: 10.1186/s12913-021-06346-y. BMC Health Serv Res. 2021. PMID: 33892716 Free PMC article.
-
Team-based primary care reforms and older adults: a descriptive assessment of sociodemographic trends and prescribing endpoints in two Canadian provinces.BMC Prim Care. 2023 Jan 10;24(1):7. doi: 10.1186/s12875-022-01960-z. BMC Prim Care. 2023. PMID: 36627566 Free PMC article.
-
Drug-related deaths among inpatients: a meta-analysis.Eur J Clin Pharmacol. 2022 Feb;78(2):267-278. doi: 10.1007/s00228-021-03214-w. Epub 2021 Oct 18. Eur J Clin Pharmacol. 2022. PMID: 34661726
-
Pharmacy's role in a modern health continuum.Can Pharm J (Ott). 2013 Nov;146(6):321-4. doi: 10.1177/1715163513506370. Can Pharm J (Ott). 2013. PMID: 24228046 Free PMC article. No abstract available.
References
-
- Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801. - PubMed
-
- Bates DW, Spell N, Cullen DJ, et al. The costs of adverse events in hospitalized patients. JAMA 1997;277:307-11. - PubMed
-
- Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med 1995;155:1949-56. - PubMed
-
- Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9. - PubMed
-
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical